Acta Obstetricia et Gynecologica Scandinavica最新文献

{"title":"AOGS in 2025: Opportunities and challenges","authors":"Amarnath Bhide","doi":"10.1111/aogs.15044","DOIUrl":"10.1111/aogs.15044","url":null,"abstract":"<p>After 10 years at the helm, Professor Ganesh Acharya has passed on the mantle of chief editorship of AOGS. Under his leadership the journal has gone from strength to strength. I am excited and intimidated in equal measures to step up as the 13th Chief Editor and the first one from outside Scandinavia. Although the team is not new to me—I have been a Deputy Chief Editor of AOGS for the last 6 years—the responsibility and expectations are certainly new. I am aware that I would be standing on the shoulders of giants.</p><p>In his editorial last month (AOGS-24-1372.R1),<span><sup>1</sup></span> Professor Acharya looked back at his time at AOGS. The journal successfully transitioned to open access publishing, maintained its ranking in the O & G journals, maintained the reputation for publishing reliable, good quality research in our specialty, and strengthened the reputation for quick and effective decision making for the submitted manuscripts. He outlined our principles—excellence, fairness, openness, and equality, that he has eschewed and I hope to emulate.</p><p>We are experiencing a marked increase in the number of submissions. Last year (2023) we dealt with 1185 submitted manuscripts, this year we are already past 1500. This makes editorial work challenging. With the support of the Nordic Federation of Societies of Obstetrics and Gynecology (NFOG), we now have two Deputy Chief Editors instead of one. I am looking forward to working with them.</p><p>We have been on the receiving end of the wrath of some of our authors for transitioning to open-access publishing. In their view, we were becoming no different from “predatory journals” that have mushroomed over the last few years. A list of such journals (beallslist.net) is available to view on the internet, and I am proud to note that AOGS does not figure on it. The Directory of Open Access Journals (DOAJ, www.doaj.org) was developed in response to discussions about predatory publishing. The decision to transform to open access publishing was that of NFOG rather than our publishers. The decision did not stem from profit making. On the contrary, the NFOG was of the opinion that research that benefits mankind should not be hidden behind paywalls and should be accessible to all. Governments of Scandic nations—bar the exception of Denmark and Iceland—support open access publishing by entering into transformational agreements with the publishers, so that the publishing charges are not borne by either the authors or the readers. However, several of our competitors are still publishing in a hybrid format and not fully open access. Another publishing model is “diamond access,” where the authors do not pay publication charges but the manuscripts are still free to view. Many such journals are published by university departments and publication charges are borne by their internal budgets or through charity support. This model has been successfully used in South America.<span><sup>2</sup></span> Unfortuna","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 1","pages":"4-5"},"PeriodicalIF":3.5,"publicationDate":"2024-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142875726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Non-daily contraception: Reinforcing the choice of users and addressing unmet needs of reproductive health","authors":"Helena Kopp Kallner,&nbsp;Ingela Lindh,&nbsp;Kristina Gemzell-Danielsson","doi":"10.1111/aogs.15014","DOIUrl":"10.1111/aogs.15014","url":null,"abstract":"<p>Despite great societal efforts promoting female autonomy, Sweden still faces unmet contraceptive needs, with abortion rates being the highest in the Nordic countries. In this commentary, we discuss using non-daily contraception options to combat these unmet needs. Non-daily methods include transdermal (i.e., patch), ring, injectables, and long-acting reversible contraception (LARC). Numerous studies have revealed that users prefer non-daily methods, and studies implementing structured counseling have revealed an increase in non-daily methods. Relative to LARC, the patch and the ring are non-daily parenteral methods that offer the possibility for self-management. Ultimately, client-centered counseling and shared decision-making are crucial for increasing awareness of all methods and enhancing method utilization and adherence. Finally, dispelling myths surrounding reversible hormonal contraception is essential for empowering women to make informed choices and improving overall reproductive health outcomes.</p>","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"253-257"},"PeriodicalIF":3.5,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of balloon catheter and oral misoprostol for cervical ripening in women with pre-labor rupture of membranes: A Finnish randomized controlled trial","authors":"Heidi Kruit,&nbsp;Leena Rahkonen","doi":"10.1111/aogs.15036","DOIUrl":"10.1111/aogs.15036","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Introduction&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Pre-labor rupture of membranes (PROM) occurs in about 8% of term pregnancies with over 70% delivering spontaneously within 24 h. However, prolonged PROM increases the risk of chorioamnionitis and neonatal sepsis. While misoprostol and oxytocin are considered safe and effective methods of labor induction, most guidelines do not encourage balloon catheter (BC) use following PROM given concerns about increased risk of chorioamnionitis. However, lack of robust evidence exists. This study aimed to compare BC and low-dose oral misoprostol (OM) regarding infectious morbidity and assess the impact of routine antibiotic prophylaxis during BC use on infection prevention.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Material and Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A randomized controlled trial comparing BC and low-dose 25 μg OM for pre-induction cervical ripening in an inpatient setting and assessing the preventive effect of prophylactic antibiotics during BC use in 175 women with PROM was carried out between 1.2.2021 and 31.12.2023 in Helsinki University Hospital. The study protocol was registered in the ISCTN registry (ISRCTN10972090). The primary outcome measures of the study were the mode of delivery, and maternal and neonatal infections.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Eighty-nine women (50.9%) were allocated in the BC arm and 86 women (49.1%) in the OM arm. The cesarean delivery rates were comparable (BC 19.1% [&lt;i&gt;n&lt;/i&gt; = 17] vs. OM 11.6% [&lt;i&gt;n&lt;/i&gt; = 10]; &lt;i&gt;p&lt;/i&gt; = 0.17). The rate of chorioamnionitis (BC 9.1% [&lt;i&gt;n&lt;/i&gt; = 8] vs. OM 3.5% [&lt;i&gt;n&lt;/i&gt; = 3]; &lt;i&gt;p&lt;/i&gt; = 0.21) or neonatal infection (BC 4.5% [&lt;i&gt;n&lt;/i&gt; = 4] vs. OM 2.3% [&lt;i&gt;n&lt;/i&gt; = 2]; &lt;i&gt;p&lt;/i&gt; = 0.68) were not statistically significantly different between the groups, although there was a trend towards higher frequency of infections in the BC arm. There were no differences in the incidence of chorioamnionitis or neonatal infections when routine antibiotic prophylaxis was administered during the BC use compared to those who did not receive antibiotics (chorioamnionitis 10.9% with antibiotics vs. 8.0% without antibiotics; &lt;i&gt;p&lt;/i&gt; = 0.68, and neonatal infection 5.3% vs. 3.9%; &lt;i&gt;p&lt;/i&gt; = 1.00). Maternal childbirth satisfaction was similar in the BC and OM groups.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Our results showed almost threefold frequency of chorioamnionitis and twofold frequency of neonatal infections following the use of BC compared to OM, although the study was underpowered for reaching statistical significance. The use of prophylactic antibiotics during BC ","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"400-407"},"PeriodicalIF":3.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142852029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction to: “Rode L, Langhoff-Roos J, Andersson C, Dinesen J, Hammerum MS, Mohapeloa H, Tabor A. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies.”","authors":"","doi":"10.1111/aogs.15045","DOIUrl":"10.1111/aogs.15045","url":null,"abstract":"<p>Rode L, Langhoff-Roos J, Andersson C, Dinesen J, Hammerum MS, Mohapeloa H, Tabor A. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand. 2009;88(11): 1180–9.</p><p>To avoid any misunderstanding regarding nomenclature, the authors of this article would like to specify that the term “progesterone” was used in the title, whereas a more appropriate term would be “progestogens.” Similarly, the term “intramuscular progesterone” used in Table III should have been “intramuscular 17α-hydroxyprogesterone caproate.” There are instances in the text where the terms “17α-hydroxyprogesterone” and “17α-hydroxyprogesterone caproate” have been used interchangeably. The authors apologize for these errors.</p>","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"430"},"PeriodicalIF":3.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142852030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ultrasound guided microwave ablation treatment of uterine fibroids: Clinical response and patient acceptability","authors":"Gudny Jonsdottir,&nbsp;Marie Beermann,&nbsp;Erika Lanz,&nbsp;Ava Nikodell,&nbsp;Annika Cronsioe,&nbsp;Klara Hasselrot,&nbsp;Helena Kopp-Kallner","doi":"10.1111/aogs.15041","DOIUrl":"10.1111/aogs.15041","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The objective of this study was to evaluate the effectiveness and acceptability of ultrasound guided microwave ablation for treating symptoms related to uterine fibroids.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Material and Methods</h3>\u0000 \u0000 <p>This was a prospective interventional study. Patients with symptomatic uterine fibroids were included at Danderyd Hospital, Sweden, from January 2020 to August 2023. All patients were treated with percutaneous or vaginal ultrasound guided microwave ablation. Primary outcome was reduction of fibroid symptoms evaluated by the validated uterine fibroid symptom and quality of life (UFS-QoL) questionnaire at 6 months post-treatment. Location of each fibroid was noted. Secondary outcomes included reduction of menstruation blood loss, change in hemoglobin, ferritin and Anti-Müllerian hormone, fibroid volume difference, hospitalization, acceptability, and postoperative pain. Clinical trials registration number NCT04240262.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Symptoms from uterine fibroids decreased by 37% (<i>p</i> &lt; 0.001) on the symptom severity scale and health-related quality of life increased by 74% (<i>p</i> &lt; 0.001). Menstrual blood loss decreased by 38% (<i>p</i> &lt; 0.001) according to the Pictorial Bleeding Assessment Chart and median fibroid shrinkage of the three largest treated fibroids was 64% (<i>p</i> &lt; 0.001). Highest median shrinkage rate (82) was seen in submucous fibroids. A total of 110 of 113 (97%) patients left the hospital on the day of treatment. We experienced one adverse event (0.8%) Clavien Dindo grade 3. Acceptability was high and postoperative pain was mild to moderate.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Microwave ablation is a highly acceptable minimally invasive method for treating symptoms related to uterine fibroids in patients who desire uterus preservation. Submucosal fibroids showed more favorable treatment results.</p>\u0000 </section>\u0000 </div>","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"350-356"},"PeriodicalIF":3.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142851988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"No uterine rupture at VBAC TOL if birth weight less than 2900 and no use of medical induction or augmentation of labor","authors":"Judy Slome Cohain","doi":"10.1111/aogs.15037","DOIUrl":"10.1111/aogs.15037","url":null,"abstract":"&lt;p&gt;Since the causes of uterine rupture at vaginal birth after cesarean (VBAC) trial of labor (TOL) are known although to date denied due to medicolegal fears, I was very curious to read the article: &lt;i&gt;Prediction of uterine rupture in singleton pregnancies with one prior cesarean birth undergoing TOLAC: A cross-sectional study&lt;/i&gt; in the November 2024 issue of your journal.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;The authors write in their Conclusions they “wish there was a more robust prediction model for uterine rupture in TOLAC.” This is a curious goal in light of the fact there already exists a robust prediction model for VBAC trial of labor after cesarean (TOLAC) uterine rupture: To eliminate VBAC TOL uterine rupture, deliver term birth weights of less than 2900 gm without induction or augmentation. Not a single case of TOL uterine rupture has been documented where uterine rupture is clearly defined, induction or augmentation are not used at all and the birth weight is 2950 kg or less. It is unfortunately also true that there is an obvious motivation to underreport the use of medical induction and Pitocin augmentation after uterine rupture occurs.&lt;/p&gt;&lt;p&gt;The US birth certificate database used in this study is not a proper tool to examine relatively rare and sometimes undocumented outcomes like uterine rupture. But there is enough data to prove that not inducing and augmenting where the birth weight is under 2950 eliminates uterine rupture in vaginal births after one cesarean (VBA1C) labors. It is impossible to know if the data on VBA1C also apply to women after multiple cesareans due to a lack of reporting on uterine rupture after two or more cesareans in the absence of medical induction or augmentation. (Anecdotally, my experience with 105 VBA2C supports that it is true for women after multiple cesareans.) In hospitals reporting 25% induction and another 25% Pitocin augmentation rates at VBA1C TOL, uterine rupture occurs at a rate of 10 per 1000 VBA1Cs.&lt;span&gt;&lt;sup&gt;2-6&lt;/sup&gt;&lt;/span&gt; In the absence of induction and augmentation, 2 per 1000 VBA1C uterine rupture occur and zero uterine rupture occurred with birth weight under 2977 gm.&lt;span&gt;&lt;sup&gt;7&lt;/sup&gt;&lt;/span&gt; From the above research, it can be derived that 10/1000–2/1000 = 8/1000 or 80% of VBA1C uterine rupture in labor is the result of medical induction and/or augmentation at VBA1C labor and the other 20% is due to birth weights over 3 kg. To eliminate VBA1C uterine rupture, deliver term birth weight less than 2900 gm without induction or augmentation. Term birth weight under 2900 are achieved by eating low glycemic diets and regular exercise such as walking for 1 to 2 h per day.&lt;span&gt;&lt;sup&gt;8&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Even using a relatively unreliable database copied from birth certificate data and not tested for accuracy, in the November 2024 study, 70% of uterine ruptures were caused by induction or augmentation of labor. The time is long overdue to teach women that a low carb diet and daily exercise produces ","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"426-427"},"PeriodicalIF":3.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142852033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The hidden impact of GLP-1 receptor agonists on endometrial receptivity and implantation","authors":"Alberto Sola-Leyva,&nbsp;Amruta D. S. Pathare,&nbsp;Apostol Apostolov,&nbsp;Elina Aleksejeva,&nbsp;Keiu Kask,&nbsp;Triin Tammiste,&nbsp;Susana Ruiz-Durán,&nbsp;Sanjiv Risal,&nbsp;Ganesh Acharya,&nbsp;Andres Salumets","doi":"10.1111/aogs.15010","DOIUrl":"10.1111/aogs.15010","url":null,"abstract":"<p>Increasing infertility rates represent a growing medical challenge in modern societies resulting from a complex interplay of sociocultural trends, lifestyle factors, exposure to environmental toxins, and underlying health problems. Women's fertility is particularly vulnerable to these shifts. The obesogenic lifestyle not only accelerates weight gain, but also disrupts ovulation driving the rise in infertility. Among several medications used for treating obesity and type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RAs) show promising improvement in female fertility most likely by stimulating ovulation. However, the effects of GLP-1RAs on the endometrium remain unclear. Further studies are needed to investigate the impact of GLP-1RAs on endometrial receptivity and embryo implantation and early development. The aim of this study is to address the knowledge gap regarding the effects of GLP-1RAs on human reproduction, with special focus on the endometrium. Understanding these mechanisms may help to develop new strategies for improving fertility treatment, reduce implantation failure and address potential safety concerns regarding teratogenicity and adverse developmental outcomes for children born to women conceiving during or soon after GLP-1RA treatment.</p>","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"258-266"},"PeriodicalIF":3.5,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782050/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142851985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of balloon catheter, oral misoprostol, or combination of both for cervical ripening in late-term and post-term nulliparous women: A Finnish randomized controlled multicenter pilot trial","authors":"Heidi Kruit,&nbsp;Katariina Place,&nbsp;Kirsi Väyrynen,&nbsp;Maija-Riitta Orden,&nbsp;Aydin Tekay,&nbsp;Marja Vääräsmäki,&nbsp;Jukka Uotila,&nbsp;Kati Tihtonen,&nbsp;Kirsi Rinne,&nbsp;Kaarin Mäkikallio,&nbsp;Seppo Heinonen,&nbsp;Leena Rahkonen","doi":"10.1111/aogs.15034","DOIUrl":"10.1111/aogs.15034","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Introduction&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Nulliparous women beyond term have high rates of induction failure. The aim of this study was to compare delivery outcomes for balloon catheter, misoprostol, and combination of both in nulliparous late- and post-term women with unfavorable cervices. We intended to explore whether the combination strategy has lower cesarean section rate and is as safe as either method alone.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Material and Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The randomized multicenter pilot trial was carried out in the five university hospitals and the largest secondary care hospital of Finland March 1, 2018–March 31, 2022. A total of 273 nulliparous women with viable singleton fetus in cephalic presentation, intact amniotic membranes, and an unfavorable cervix at 41 + 0 gestational weeks were included. The study protocol was registered in the ISCTN registry (ISRCTN83219789). The women were randomized into cervical ripening by balloon catheter, oral misoprostol 50 μg every 4 h, or the combination use of both. The primary outcomes of the study were the rates of cesarean section and composite of adverse neonatal outcomes (5-min Apgar score &lt;7, umbilical artery pH ≤7.05, or NICU admission).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Ninety-seven women (35.5%) were allocated in the balloon catheter arm, 94 (34.4%) in the oral misoprostol arm, and 82 (30.0%) in the combination treatment arm. The rates of cesarean section (balloon catheter 23.7%, &lt;i&gt;n&lt;/i&gt; = 23/97, vs. oral misoprostol 24.5%, &lt;i&gt;n&lt;/i&gt; = 23/94, vs. combination 17.1%, &lt;i&gt;n&lt;/i&gt; = 14/82) or composite adverse neonatal outcome (7.2% vs. 7.4% vs. 7.3%, respectively) were not statistically significantly different between the groups. The median (interquartile range) induction to delivery interval was the shortest in the combination treatment, 21.7 (15.1–33.2) h compared to balloon catheter 31.7 (21.9–44.5) h; &lt;i&gt;p&lt;/i&gt; &lt; 0.01 or oral misoprostol 37.0 (26.7–60.3) h; &lt;i&gt;p&lt;/i&gt; &lt; 0.01. The proportion of women with induction to delivery interval ≤24 h was significantly higher in the combination arm compared to balloon catheter (54.4% vs. 31.1%; &lt;i&gt;p&lt;/i&gt; &lt; 0.01) or oral misoprostol (54.4% vs. 21.1%; &lt;i&gt;p&lt;/i&gt; &lt; 0.001).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Our findings confirm the effectiveness of combining balloon catheter and oral misoprostol for cervical ripening, showing shorter induction to delivery interval and comparable rates of cesarean section and neonatal outcomes compared to either method alone. These results advocate for a shift toward adopting com","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"389-399"},"PeriodicalIF":3.5,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142823983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Women's perspectives to improve prenatal care for gestational diabetes: A systematic review and meta-aggregation of qualitative studies","authors":"Yuyang Julianne Feng,&nbsp;Zhidi Deng,&nbsp;Allison Sivak,&nbsp;Roseanne O. Yeung,&nbsp;Taniya Nagpal","doi":"10.1111/aogs.14973","DOIUrl":"10.1111/aogs.14973","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>In numerous qualitative primary studies, women have identified opportunities to improve prenatal gestational diabetes care. The objective of our systematic review and meta-aggregation was to synthesize patient-guided suggestions for improving prenatal gestational diabetes care that are informed by lived experience of women and their support persons.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Material and Methods</h3>\u0000 \u0000 <p>This study was registered a priori on PROSPERO (CRD42023394014). Our search strategy was executed in five databases (Medline, PsycInfo, CINAHL, Scopus, and Web of Science). Primary studies that were qualitative, had full texts in English, studied women who have or had gestational diabetes or their support persons, and included experiential accounts on prenatal gestational diabetes care were included. No date restrictions were applied. Studies that were not qualitative, were secondary analyses, included data on only postpartum care, or evaluated an intervention that was not standard care were excluded. Two independent authors used Covidence software to facilitate screening. The outcomes of interest were patient-reported suggestions to improve quality of gestational diabetes care that are informed by women's or their support persons' accounts of the lived experience of gestational diabetes. Meta-aggregation followed by a thematic synthesis approach was used to analyze the qualitative data to identify women's perspectives to improve gestational diabetes care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>After duplicate removal, a total of 4761 studies underwent screening and a total of 80 studies were ultimately included. Patient- and support persons-reported suggestions to improve care include timely and comprehensive education around gestational diabetes with active engagement of family members, personalized and tailored counseling, patient-centered care, incorporation of digital or online adjuncts to care, and increasing support for women.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our systematic review and meta-aggregation identifies several actionable and patient-guided suggestions to improve prenatal gestational diabetes care that are important to consider when embarking on clinical quality improvement.</p>\u0000 </section>\u0000 </div>","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"267-287"},"PeriodicalIF":3.5,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142798698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is the Finnish grip tight enough? A manometric study of two manual perineal protection techniques","authors":"Zdenek Rusavy,&nbsp;Hana Cechova,&nbsp;Sebastian Dendorfer,&nbsp;Vladimir Kalis,&nbsp;Khaled M. Ismail","doi":"10.1111/aogs.15033","DOIUrl":"10.1111/aogs.15033","url":null,"abstract":"<p>The use of middle finger in Finnish maneuver does not compromise the capacity of the dominant hand to disperse tension from the midline of the perineum.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"423-425"},"PeriodicalIF":3.5,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}